Antihistaminic, Anti-Inflammatory, and Antiallergic Properties of the Nonsedating Second-Generation Antihistamine Desloratadine: a Review of the Evidence

This publication has 59 references indexed in Scilit:

• Desloratadine Inhibits Human Skin Mast Cell Activation and Histamine Release
  Journal of Investigative Dermatology, 2009
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
  Allergy, 2008
• Efficacy and Safety of Desloratadine in Adults with Chronic Idiopathic Urticaria
  American Journal of Clinical Dermatology, 2007
• Desloratadine for Chronic Idiopathic Urticaria
  American Journal of Clinical Dermatology, 2007
• Desloratadine therapy for symptoms associated with perennial allergic rhinitis
  Annals of Allergy, Asthma & Immunology, 2006
• Histamine receptors are hot in immunopharmacology
  European Journal of Pharmacology, 2006
• Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial
  Annals of Allergy, Asthma & Immunology, 2006
• Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI⁺cells
  Clinical & Experimental Allergy, 1997
• Pharmacological modulation of IL‐6 and IL‐8 secretion by the H₁‐antagonist decarboethoxy‐loratadine and dexamethasone by human mast and basophilic cell lines
  Experimental Dermatology, 1995
• Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM‐1 and HLA‐DR by nasal epithelial cells
  Allergy, 1995